Manufacturer
7 recalls in our database name Gilead Sciences, Inc. as the manufacturing or recalling firm.
Of the 7 recalls from Gilead Sciences, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (43%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Gilead Sciences recalls 105,000 vials of Veklury (remdesivir) for injection nationwide because glass particles are present in the medication.
Gilead Sciences is recalling Veklury (remdesivir) injection vials nationwide due to the presence of glass particulates detected during a customer complaint investigation. The affected lots are 2141001-1A and 2141002-1A with expiration date 01/2024.
Gilead Sciences is recalling 6,290 bottles of Emtriva Oral Solution because the containers are defective and leaking around the cap.
Gilead Sciences is recalling Truvada tablets because they contain small red silicone rubber particulates. The recall affects 10,317 bottles distributed nationwide.
Gilead Sciences is recalling specific lots of Atripla tablets because they contain red silicone rubber particulates. The recall covers 39,223 bottles distributed nationwide.
Gilead Sciences is recalling 478,352 vials of AmBisome (amphotericin B) liposome for Injection due to a lack of sterility assurance detected during routine manufacturing simulations.
Gilead Sciences is recalling Vistide (cidofovir) injection vials because particulate matter was found in some units. The recall covers 3,181 vials distributed in the US, Canada, and UK.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Gilead Sciences
American biopharmaceutical company
Source: Wikidata (Q663596), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.